695 related articles for article (PubMed ID: 32960454)
1. Glucagon-like peptide 2 attenuates intestinal mucosal barrier injury through the MLCK/pMLC signaling pathway in a piglet model.
Chang Y; Deng Q; Zhang Z; Zhao H; Tang J; Chen X; Liu G; Tian G; Cai J; Jia G
J Cell Physiol; 2021 Apr; 236(4):3015-3032. PubMed ID: 32960454
[TBL] [Abstract][Full Text] [Related]
2. Myosin light chain kinase mediates intestinal barrier dysfunction via occludin endocytosis during anoxia/reoxygenation injury.
Jin Y; Blikslager AT
Am J Physiol Cell Physiol; 2016 Dec; 311(6):C996-C1004. PubMed ID: 27760753
[TBL] [Abstract][Full Text] [Related]
3. PEGylated porcine glucagon-like peptide-2 improved the intestinal digestive function and prevented inflammation of weaning piglets challenged with LPS.
Qi KK; Wu J; Deng B; Li YM; Xu ZW
Animal; 2015 Sep; 9(9):1481-9. PubMed ID: 25963800
[TBL] [Abstract][Full Text] [Related]
4. Chang'an II Decoction ( II )-Containing Serum Ameliorates Tumor Necrosis Factor-α-Induced Intestinal Epithelial Barrier Dysfunction via MLCK-MLC Signaling Pathway in Rats.
Chen T; Yin XL; Kang N; Wang XG; Li BS; Ji HJ; Zhang YQ; Bian LQ; Zhang BH; Wang FY; Tang XD
Chin J Integr Med; 2020 Oct; 26(10):745-753. PubMed ID: 31768870
[TBL] [Abstract][Full Text] [Related]
5. Amelioration of IFN-γ and TNF-α-induced intestinal epithelial barrier dysfunction by berberine via suppression of MLCK-MLC phosphorylation signaling pathway.
Cao M; Wang P; Sun C; He W; Wang F
PLoS One; 2013; 8(5):e61944. PubMed ID: 23671580
[TBL] [Abstract][Full Text] [Related]
6. Chenodeoxycholic Acid (CDCA) Protects against the Lipopolysaccharide-Induced Impairment of the Intestinal Epithelial Barrier Function via the FXR-MLCK Pathway.
Song M; Ye J; Zhang F; Su H; Yang X; He H; Liu F; Zhu X; Wang L; Gao P; Shu G; Jiang Q; Wang S
J Agric Food Chem; 2019 Aug; 67(32):8868-8874. PubMed ID: 31319027
[TBL] [Abstract][Full Text] [Related]
7. Total polysaccharides of the Sijunzi decoction attenuate tumor necrosis factor-α-induced damage to the barrier function of a Caco-2 cell monolayer
Lu Y; Li L; Zhang JW; Zhong XQ; Wei JA; Han L
World J Gastroenterol; 2018 Jul; 24(26):2867-2877. PubMed ID: 30018481
[TBL] [Abstract][Full Text] [Related]
8. The prolonged effect of glucagon-like peptide 2 pretreatment on growth performance and intestinal development of weaned piglets.
Deng QH; Jia G; Zhao H; Chen ZL; Chen XL; Liu GM; Wang KN
J Anim Sci Biotechnol; 2016; 7():28. PubMed ID: 27148449
[TBL] [Abstract][Full Text] [Related]
9. Naringin attenuates MLC phosphorylation and NF-κB activation to protect sepsis-induced intestinal injury via RhoA/ROCK pathway.
Li Z; Gao M; Yang B; Zhang H; Wang K; Liu Z; Xiao X; Yang M
Biomed Pharmacother; 2018 Jul; 103():50-58. PubMed ID: 29635128
[TBL] [Abstract][Full Text] [Related]
10.
Gao J; Cao S; Xiao H; Hu S; Yao K; Huang K; Jiang Z; Wang L
Front Immunol; 2022; 13():897395. PubMed ID: 35911699
[TBL] [Abstract][Full Text] [Related]
11. Cathelicidin-BF ameliorates lipopolysaccharide-induced intestinal epithelial barrier disruption in rat.
Han F; Lu Z; Liu Y; Xia X; Zhang H; Wang X; Wang Y
Life Sci; 2016 May; 152():199-209. PubMed ID: 27018068
[TBL] [Abstract][Full Text] [Related]
12. Adrenomedullin improves intestinal epithelial barrier function by downregulating myosin light chain phosphorylation in ulcerative colitis rats.
Yi Z; Fan H; Liu X; Tang Q; Zuo D; Yang J
Mol Med Rep; 2015 Sep; 12(3):3615-3620. PubMed ID: 26043783
[TBL] [Abstract][Full Text] [Related]
13. Wogonoside alleviates colitis by improving intestinal epithelial barrier function via the MLCK/pMLC2 pathway.
Huang S; Fu Y; Xu B; Liu C; Wang Q; Luo S; Nong F; Wang X; Huang S; Chen J; Zhou L; Luo X
Phytomedicine; 2020 Mar; 68():153179. PubMed ID: 32062328
[TBL] [Abstract][Full Text] [Related]
14. Tetrastigma hemsleyanum Diels et Gilg ameliorates lipopolysaccharide induced sepsis via repairing the intestinal mucosal barrier.
Zhan L; Pu J; Zheng J; Hang S; Pang L; Dai M; Ji C
Biomed Pharmacother; 2022 Apr; 148():112741. PubMed ID: 35217279
[TBL] [Abstract][Full Text] [Related]
15. Myosin light chain kinase mediates intestinal barrier disruption following burn injury.
Chen C; Wang P; Su Q; Wang S; Wang F
PLoS One; 2012; 7(4):e34946. PubMed ID: 22529961
[TBL] [Abstract][Full Text] [Related]
16. Dexmedetomidine protects against burn-induced intestinal barrier injury via the MLCK/p-MLC signalling pathway.
Qin C; Jiang Y; Chen X; Bian Y; Wang Y; Xie K; Yu Y
Burns; 2021 Nov; 47(7):1576-1585. PubMed ID: 33933302
[TBL] [Abstract][Full Text] [Related]
17. TNFR2 activates MLCK-dependent tight junction dysregulation to cause apoptosis-mediated barrier loss and experimental colitis.
Su L; Nalle SC; Shen L; Turner ES; Singh G; Breskin LA; Khramtsova EA; Khramtsova G; Tsai PY; Fu YX; Abraham C; Turner JR
Gastroenterology; 2013 Aug; 145(2):407-15. PubMed ID: 23619146
[TBL] [Abstract][Full Text] [Related]
18. Total Flavonoid Extract from Hawthorn (Crataegus pinnatifida) Improves Inflammatory Cytokines-Evoked Epithelial Barrier Deficit.
Liu F; Zhang X; Ji Y
Med Sci Monit; 2020 Feb; 26():e920170. PubMed ID: 32065826
[TBL] [Abstract][Full Text] [Related]
19. Porcine glucagon-like peptide-2 microspheres ameliorate inflammation in lipopolysaccharide-challenged weaning piglets.
Wu J; Qi KK; Xu ZW
J Anim Sci; 2016 Dec; 94(12):5286-5294. PubMed ID: 28046174
[TBL] [Abstract][Full Text] [Related]
20. Rebeccamycin Attenuates TNF-α-Induced Intestinal Epithelial Barrier Dysfunction by Inhibiting Myosin Light Chain Kinase Production.
Watari A; Sakamoto Y; Hisaie K; Iwamoto K; Fueta M; Yagi K; Kondoh M
Cell Physiol Biochem; 2017; 41(5):1924-1934. PubMed ID: 28391269
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
